Perspective Therapeutics, Inc.

Q4 2024 13F Holders

Symbol
CATX
CUSIP
46489V302
Type
Equity
Class
COM NEW
Num filings
141
Total reported value, excl. options
$150 M
Manager Report Date Value ($000) Shares Option Type